These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1064 related articles for article (PubMed ID: 26457017)
1. Biomarkers for the early diagnosis of hepatocellular carcinoma. Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017 [TBL] [Abstract][Full Text] [Related]
2. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma. Van Hees S; Michielsen P; Vanwolleghem T World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. Unić A; Derek L; Duvnjak M; Patrlj L; Rakić M; Kujundžić M; Renjić V; Štoković N; Dinjar P; Jukic A; Grgurević I Ann Clin Biochem; 2018 May; 55(3):355-362. PubMed ID: 28766361 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346 [TBL] [Abstract][Full Text] [Related]
5. Clinical biomarkers in hepatocellular carcinoma (HCC). Donati M; Brancato G; Donati A Front Biosci (Schol Ed); 2010 Jan; 2(2):571-7. PubMed ID: 20036969 [TBL] [Abstract][Full Text] [Related]
6. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C. Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063 [TBL] [Abstract][Full Text] [Related]
7. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Best J; Bilgi H; Heider D; Schotten C; Manka P; Bedreli S; Gorray M; Ertle J; van Grunsven LA; Dechêne A Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479 [No Abstract] [Full Text] [Related]
8. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875 [TBL] [Abstract][Full Text] [Related]
9. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma. Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892 [TBL] [Abstract][Full Text] [Related]
10. New perspectives and strategy research biomarkers for hepatocellular carcinoma. Saffroy R; Pham P; Reffas M; Takka M; Lemoine A; Debuire B Clin Chem Lab Med; 2007; 45(9):1169-79. PubMed ID: 17635075 [TBL] [Abstract][Full Text] [Related]
11. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders. Wong RJ; Ahmed A; Gish RG Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665 [TBL] [Abstract][Full Text] [Related]
12. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma. Chen VL; Sharma P Clin Liver Dis; 2020 Nov; 24(4):577-590. PubMed ID: 33012446 [TBL] [Abstract][Full Text] [Related]
13. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors]. Li J; Wei L Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815 [TBL] [Abstract][Full Text] [Related]
14. Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: Expectation. Gao J; Song P Drug Discov Ther; 2017; 11(3):168-169. PubMed ID: 28757516 [TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxyprothrombin for early identification and prognosis of hepatocellular carcinoma--a case control study from western Nepal. Mittal A; Gupta SP; Sathian B; Sreedharan J; Poudel B; Yadav SK; Pandeya DR Asian Pac J Cancer Prev; 2012; 13(11):5773-5. PubMed ID: 23317255 [TBL] [Abstract][Full Text] [Related]
16. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics. Masuda T; Miyoshi E Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856 [TBL] [Abstract][Full Text] [Related]
18. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]. Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of hepatocellular carcinoma. Gomaa AI; Khan SA; Leen EL; Waked I; Taylor-Robinson SD World J Gastroenterol; 2009 Mar; 15(11):1301-14. PubMed ID: 19294759 [TBL] [Abstract][Full Text] [Related]
20. Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi Patients. Farag RMA; Al Ayobi D; Alsaleh KA; Kwon HJ; EL-Ansary A; Dawoud EA Asian Pac J Cancer Prev; 2019 Jan; 20(1):215-220. PubMed ID: 30678434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]